Helios Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,200
Closed -$1.28M 30
2025
Q4
$1.28M Hold
6,200
0.88% 24
2025
Q3
$1.15M Hold
6,200
0.78% 25
2025
Q2
$947K Hold
6,200
0.73% 27
2025
Q1
$1.03M Hold
6,200
1.8% 13
2024
Q4
$897K Hold
6,200
0.52% 34
2024
Q3
$1M Hold
6,200
0.62% 32
2024
Q2
$906K Hold
6,200
0.59% 33
2024
Q1
$981K Hold
6,200
0.69% 34
2023
Q4
$972K Buy
+6,200
New +$951K 0.77% 32
2022
Q3
$1.01M Hold
6,200
1.94% 18
2022
Q2
$1.1M Hold
6,200
2.08% 17
2022
Q1
$1.1M Hold
6,200
2.32% 14
2021
Q4
$1.06M Buy
+6,200
New +$1.02M 0.96% 40

Other funds holding JNJ

Helios Capital Management's JNJ Position: Q1 2026 in Review

Helios Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 6,200 shares — an estimated $1.28M sold.

Helios Capital Management first reported a position in JNJ in Q4 2021 and held it in 13 quarters. The position peaked at $1.28M in Q4 2025. 4,639 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Helios Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Helios Capital Management sold 6,200 Johnson & Johnson shares in Q1 2026, an estimated $1.28M.
  • Helios Capital Management first reported a position in Johnson & Johnson in Q4 2021 and held it in 13 quarters.
  • Helios Capital Management's Johnson & Johnson position peaked at $1.28M in Q4 2025.
  • 4,639 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Helios Capital Management's 13F filing for Q1 2026, filed 5 May 2026.